INIS
cancer
100%
breasts
41%
screening
35%
reviews
27%
colombia
24%
latin america
23%
patients
19%
women
19%
income
18%
humans
17%
lenses
17%
populations
17%
covid-19
11%
medicine
11%
medicines
11%
risks
10%
data
9%
diseases
8%
guidelines
8%
people
7%
interventions
7%
cost
7%
testing
7%
medical personnel
7%
assessments
6%
recommendations
6%
sensitivity
6%
performance
6%
death
6%
detection
6%
hiv
5%
vaccines
5%
mobile phones
5%
morphology
5%
accuracy
5%
interactions
5%
validation
5%
radiations
5%
genetics
5%
receptors
5%
radiotherapy
5%
attitudes
5%
growth factors
5%
implementation
5%
quality assurance
5%
dimensions
5%
correlations
5%
indicators
5%
information
5%
Medicine and Dentistry
Malignant Neoplasm
26%
Breast Cancer
23%
Cervical Cancer Screening
23%
Systematic Review
23%
Oncology
18%
Breast Cancer Screening
17%
COVID-19
17%
Diseases
12%
Triage
11%
Complementary and Alternative Medicine
11%
Screening
11%
Mammography
10%
Radiation Therapy
10%
Cytotechnology
9%
Cervical Cancer
7%
Health Care Cost
7%
Low and Middle Income Countries
7%
Public Health
7%
Cancer Diagnosis
6%
Wart Virus
5%
Meta-Analysis
5%
Cancer Prevention
5%
Early Cancer Detection
5%
Cost-Effectiveness Analysis
5%
Uterine Cervix Cytology
5%
Cognitive Change
5%
Attitude Scale
5%
Mobile Health
5%
Cancer Research
5%
Radiation Oncologist
5%
Radiation Oncology
5%
COVID-19 Vaccination
5%
Nicotine Withdrawal
5%
Nicotine Replacement Therapy
5%
Keyphrases
Breast Cancer Screening
5%
Smoking Cessation
5%
Determinants of Participation
5%
Radiation Oncology
5%
Screening Study
5%
High-risk Human Papillomavirus Infection
5%
High-risk Human Papillomavirus (HR-HPV)
5%
ESTAMPA
5%
People Living with HIV (PLHIV)
5%
Triage Methods
5%
Voice Message
5%
Mobile Phone Messages
5%
Cancer Prevention
5%
MHealth
5%
Human Papillomavirus Vaccine
5%
Screening Services
5%
Morphology-based
5%
Alternative Medicine
5%
Moral Distress
5%
Stress Resilience
5%
Persuasiveness
5%
Breast Cancer Risk Reduction
5%
Primary Cervical Cancer Screening
5%
Cervical HPV
5%
Radiation Oncologist
5%
Intraoperative Radiation Therapy
5%
Guideline Development
5%
Hypofractionation
5%
Human Epidermal Growth Factor Receptor
5%
Phased Approach
5%